Binaltorphimine
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(1S,2S,7S,8S,12R,20R,24R,32R)-11,33-bis(cyclopropylmethyl)-22-methyl-19,25-dioxa-11,22,33-triazaundecacyclo[24.9.1.18,14.01,24.02,32.04,23.05,21.07,12.08,20.018,37.030,36]heptatriaconta-4(23),5(21),14(37),15,17,26(36),27,29-octaene-2,7,17,27-tetrol | |
| Identifiers | |
| CAS Number | 105618-27-7 |
| ATC code | None |
| PubChem | CID 5484197 |
| ChemSpider | 4588407 |
| Chemical data | |
| Formula | C41H45N3O6 |
| Molar mass | 675.813 g/mol |
| |
| |
Binaltorphimine (BNI) is a selective antagonist of the κ-opioid receptor (KOR).[1] BNI and norbinaltorphimine (nor-BNI) were the first highly selective KOR antagonists to be discovered.[1]
See also
References
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
